ISSN: 1871-5257

Journal Home

Journal Guideline

Cardiovascular and Hematological Agents in Medicinal Chemistry Q3 Unclaimed

Bentham Science Publishers B.V. United Arab Emirates

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Cardiovascular and Hematological Agents in Medicinal Chemistry is a journal indexed in SJR in Medicine (miscellaneous) and Pharmacology with an H index of 43. It has an SJR impact factor of 0,356 and it has a best quartile of Q3. It has an SJR impact factor of 0,356.

Type: Journal

Type of Copyright:

Languages:

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Cardiology and Cardiovascular Medicine (Q3) Hematology (Q3) Medicine (miscellaneous) (Q3) Pharmacology (Q3)

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

Cardiovascular and Hematological Agents in Medicinal Chemistry

0,356

SJR Impact factor

43

H Index

24

Total Docs (Last Year)

64

Total Docs (3 years)

958

Total Refs

90

Total Cites (3 years)

56

Citable Docs (3 years)

1.28

Cites/Doc (2 years)

39.92

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Swiss Medical Weekly Q3
Neurologia Q3
Canadian Journal of Experimental Psychology Q3
Journal of Physiology and Pharmacology Q3
Revista do Instituto de Medicina Tropical de Sao Paulo Q3

Compare this journals

Aims and Scope

Best articles by citations

Systemic Hypertension in Patients with Aortic Stenosis: Clinical Implications and Principles of Pharmacological Therapy

Active Phytochemicals from Chinese Herbs as Therapeutic Agents for the Heart

Fibrin Binding and the Regulation of Plasminogen Activators during Thrombolytic Therapy

Late Sodium Current is a New Therapeutic Target to Improve Contractility and Rhythm in Failing Heart

Evaluation on Clot Buster Activity of Staphylokinase from Staphylococcus sp.

Thromboxane A Synthase: A New Target for the Treatment of Cardiovascular Diseases

Meet Our Editorial Board Member

New Perspectives to Repair a Broken Heart

VEGF in the Muscular Layer of Placental Blood Vessels: Immuno- Expression in Preeclampsia and Intrauterine Growth Restrictrion and its Association with the Antioxidant Status

Gene-Activators Prevent and Regress Atherosclerosis and Reduce Mortality

Sex Steroid Hormones, Cardiovascular Diseases and The Metabolic Syndrome

Ivabradine for Treatment of Coronary Artery Disease: From Last Chance Resort to Mainstem of a Reasoned Therapy

SHOW MORE ARTICLES

Editorial (Thematic Issue: Novel Oral Anticoagulants; "All that Glitters is not Gold, or is it?")

Glucose Lowering Activity of the Aqueous Extract of Warionia saharae in Normal and Diabetic Rats

Eidtorial from Editor-in-Chief : [ Keeping up with Advances in Cardiovascular and Hematological Medicine in 2012 ]

Effect of a Dihydropyridine-Type Calcium Channel Blocker on Vascular Remodelling after Experimental Balloon Angioplasty

Troponin in Newborns and Pediatric Patients

Current Status of Antiplatelet Therapy in Acute Coronary Syndrome

L-Arginine Analogs -Inactive Markers or Active Agents in Atherogenesis?

Aqueous Extract of Argania spinosa L. Fruits Ameliorates Diabetes in Streptozotocin-Induced Diabetic Rats

Acute Phase Proteins In Atherosclerosis (Acute Coronary Syndrome)

Management and Outcome of Heparin-Induced Thrombocytopenia in Pregnancy: A Systematic Review

Recent Developments in Pharmacologic Prophylaxis of Atrial Fibrillation in Patients Undergoing Surgical Revascularization

Beta-Blockers and Nitrates: Pharmacotherapy and Indications